University of Minnesota Trials Cognitive Strategies in Early Psychosis with Modafinil and D-Serine
A clinical trial is investigating the effects of modafinil and d-serine on decision making in individuals with psychosis spectrum disorders.
Phase III
Psychiatry / Psychosis Spectrum Disorders
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This clinical trial explores innovative therapeutic strategies for psychosis, which could reshape treatment paradigms in psychiatry. Successful outcomes may lead to new interventions, enhancing the competitive landscape for companies involved in psychotropic drug development.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from the trial, particularly changes in decision making and brain activity post-administration of study agents.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.